Skip to main content
SpringerLink
Log in

Cost savings with RSV prophylaxis in preterm infants

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2018 Canadian dollars

  2. weeks gestational age

Reference

  • Papenburg J, et al. Cost-analysis of Withdrawing Immunoprophylaxis for Respiratory Syncytial Virus in Infants Born at 33-35 Weeks Gestational Age in Quebec: A Multicenter Retrospective Study. Pediatric Infectious Disease Journal : 5 May 2020. Available from: URL: http://doi.org/10.1097/INF.0000000000002719

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cost savings with RSV prophylaxis in preterm infants. PharmacoEcon Outcomes News 854, 13 (2020). https://doi.org/10.1007/s40274-020-6843-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6843-0

Search

Navigation